| 齐欣.非维生素K拮抗剂类口服抗凝药在老年非瓣膜性心房颤动患者中的应用[J].中国临床保健杂志,2020,23(6):844-847. |
| 非维生素K拮抗剂类口服抗凝药在老年非瓣膜性心房颤动患者中的应用 |
| Application of Non-vitamin K oral anticoagulants in elderly patients with non-valvular atrial fibrillation |
| 投稿时间：2020-06-26 |
| DOI：10.3969/J.issn.1672-6790.2020.06.030 |
| 中文关键词: 心房颤动 抗凝药 治疗结果 老年人 综述 |
| 英文关键词: Atrial fibrillation Anticoagulants Treatment outcome Aged Review 〖FL |
| 基金项目:“重大新药创制”科技重大专项资助项目(2017ZX09304026) |
|
| 摘要点击次数: 5526 |
| 全文下载次数: 3913 |
| 中文摘要: |
| 非维生素K拮抗剂类口服抗凝药(NOACs)是目前各国指南推荐的一线治疗。但是,老年心房颤动患者非常特殊,年龄既是血栓栓塞事件的独立危险因素,也是出血的独立危险因素。本文主要回顾和量化NOACs在老年心房颤动人群中的相对疗效和安全性。 |
| 英文摘要: |
| Non-vitamin K oral anticoagulants (NOACs) is currently the first-line treatment recommended by Guidelines.However,elderly patients with atrial fibrillation are very special.Age is an independent risk factor for both thromboembolic events and bleeding.This paper reviews and quantifies the relative efficacy and safety of NOACs in elderly patients with atrial fibrillation. |
|
查看全文
|
| 关闭 |